CLINICAL_TRIALS
research
· 2025-09-09
Clinical Trial Update: MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer [NA]
Summary
A Mayo Clinic-sponsored clinical trial is evaluating MRI-guided transurethral urethral ultrasound ablation for low- to intermediate-grade prostate cancer and is…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Mayo Clinic | Conditions: Prostate Carcinoma, Stage I Prostate Cancer AJCC v8 | NA | Status: RECRUITING